Magnesium Sulphate and Eclampsia Management in Prehospital Setting

This report provides a comprehensive overview of magnesium sulphate and its application in managing preeclampsia and eclampsia within the prehospital setting. It defines preeclampsia, outlines the pharmacological actions of magnesium sulphate, including administration routes, dosages, dissemination, excretion, and toxicity considerations. The report details the drug's effects on the nervous and cardio-respiratory systems, as well as its impact on the fetus and contractions. It also covers drug interactions, particularly with nifedipine, and compares current guidelines with contemporary evidence, including treatment criteria and implications for paramedic practice. The report references relevant guidelines from the Queensland Ambulance Service and includes key signs, symptoms, and references to support the information presented. The analysis is based on the provided assignment brief which includes information on preeclampsia risk factors and management protocols.